.

Investor

OncoCyte Senior Management Rings NYSE Opening Bell

Investor Relations

OncoCyte is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.

 

 

 

Corporate Profile

 

OncoCyte Chairman and CEO at Bell ringing ceremony

Stock Information
Events & Presentation

No upcoming events scheduled at this time.

Latest News
OncoCyte Announces Publication of Breast Cancer Diagnostic Test Abstract; Poster to be Presented at the San Antonio Breast Cancer Symposium on December 9, 2016
OncoCyte Reports Third Quarter 2016 Financial Results